OTC医薬品と栄養補助食品市場レポート：2024-2034

OTC Drugs & Dietary Supplements Market Report 2024-2034

レポート詳細 OTC医薬品と栄養補助食品レポート 2024-2034 ：この調査レポートは、業界とその基礎となるダイナミクスをより良く理解することを望むなら、新たな収益ポケットを目指す大手企業にとって... もっと見る

出版社	出版年月	電子版価格	ページ数	図表数	言語
Visiongain ヴィジョンゲイン社	2023年12月11日	GBP5,150 部署ライセンスライセンス・価格情報・注文方法はこちら	337	315	英語

※上記価格は部署ライセンス（Departmental licence）価格です。
その他の価格についてはデータリソースまでお問合せください。
日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。

目次
図表リスト

サマリー

レポート詳細

OTC医薬品と栄養補助食品レポート 2024-2034：この調査レポートは、業界とその基礎となるダイナミクスをより良く理解することを望むなら、新たな収益ポケットを目指す大手企業にとって貴重なものとなるであろう。異業種への進出や、新たな地域での既存事業の拡大を目指す企業にも有用です。

医療用医薬品から一般用医薬品へ移行する製薬会社
医療用医薬品が主流だった従来の医薬品モデルは、変革期を迎えている。製薬会社は、一般用医薬品やサプリメントへの需要の高まりに対応するため、戦略的に焦点を再編成している。この転換の背景には、消費者の嗜好の変化、セルフケア意識の進歩、市場拡大の可能性など、さまざまな要因がある。この変遷の主な影響のひとつは、消費者にとって薬が手に入りやすくなったことである。OTC医薬品やサプリメントは、処方箋を必要とせずに一般的な病気に対処できる便利な手段を提供し、個人が自分の健康を管理する力を与えてくれる。このシフトは、自己管理型ヘルスケアや予防的ウェルネスを目指す、より広範な世界的トレンドと一致している。業界が進化を続ける中、こうした変化が消費者行動、市場力学、規制環境をどのように形成するかを監視することは不可欠である。現在進行中の変革は、ヘルスケアにおける重要な一里塚を意味し、健康管理における個人のエンパワーメントの重要性を強調している。

進化する規制標準化は成長を制限する
規制機関の進化がもたらす重要な影響のひとつは、調和と標準化の追求である。OTC医薬品やサプリメントの評価・承認プロセスにおける一貫性を確保するため、規制機関は世界的に規格の整合化に取り組んでいる。この動きは、市場アクセスを合理化し、貿易障壁を削減し、消費者が入手できる製品の全体的な品質と安全性を高めることを目的としている。規制の枠組みを変えることは、厳格なガイドラインと監視の仕組みを導入することで、消費者の安全と信頼を優先させることである。透明性、明確な表示、包括的な製品情報の重視は、OTC製品に対する消費者の信頼を高めている。規制機関は、OTC医薬品とサプリメントが最高水準の品質と有効性を満たすことを保証する上で、極めて重要な役割を果たしている。規制の変化は良い結果をもたらす一方で、業界関係者にとっては課題でもある。新たなコンプライアンス要件に対応するためには多大なリソースを必要とする場合があり、企業は自社製品が最新の基準に適合するよう、進化する状況をナビゲートしなければならない。規制の変化に対する継続的な監視と調整の必要性は、OTC市場で成功を維持するための重要な側面である。規制機関の変化の影響は国境を越え、グローバルなOTC市場のダイナミクスに影響を及ぼす。複数の地域で事業を展開する企業は、多様な規制環境を乗りこなし、さまざまな要件に適合するよう戦略を適応させなければならない。各地域の規制を遵守しながらグローバルな存在感を示そうと努力する企業にとって、これは課題であると同時にチャンスでもある。

市場調査レポートを購入する前にすべき質問とは？
- OTC医薬品と栄養補助食品市場はどのように進化しているのか？
- OTC医薬品と栄養補助食品市場の促進要因と抑制要因は何か？
- OTC医薬品と栄養補助食品の各サブマーケットセグメントは予測期間中にどのように成長し、2034年にはどれくらいの売上を占めるようになるのか？
- 2024年から2034年にかけて、OTC医薬品と栄養補助食品の各サブマーケットの市場シェアはどのように推移するのか？
- 2024年から2034年までの市場全体の主な牽引役は何か？
- 主要なOTC医薬品と栄養補助食品市場はマクロ経済の動きに幅広く追随するのか、それとも個々の国市場が他を凌駕するのか？
- 2033年までに各国市場のシェアはどう変化し、2034年にはどの地域が市場をリードするのか？
- 主要プレーヤーと予測期間中の見通しは？
- これらの大手企業のOTC医薬品と栄養補助食品プロジェクトは？
- 2024年から2034年の間に、業界はどのように発展していくのか？現在および今後10年間に実施されるOTC医薬品と栄養補助食品プロジェクトの意味合いは？
- OTC医薬品と栄養補助食品市場をさらに拡大するために、製品化の必要性は高まっていますか？
- OTC医薬品と栄養補助食品市場はどこへ向かっているのか？
- 新製品・新サービスへの最適な投資方法とは？
- 企業を新たな成長軌道に乗せ、C-suiteに移行させるための重要な展望とは？

このことがOTC医薬品と栄養補助食品市場に現在、そして今後10年間でどのような影響を与えるかを知る必要があります：
- 本レポートは全337ページ、123の表と192の図表で構成されています。
- 本レポートでは、業界の主要な儲かる分野をハイライトしているため、今すぐターゲットを絞ることができます。
- 世界、地域、国の売上と成長に関する詳細な分析が含まれています。
- 競合他社が成功した主なトレンド、変化、収益予測をハイライトしています。

本レポートは、OTC医薬品と栄養補助食品市場が今後10年間でどのように発展し、COVID-19の景気後退と好転の変動に合わせて変化するかをお伝えします。この市場は、過去10年間のどの時点よりも今が重要である。

2034年までの予測やその他の分析から、商業的な展望が明らかになる
- 2034年までの収益予測に加え、直近の実績、成長率、市場シェアを提供します。
- ビジネスの展望と展開に関する独自の分析をご覧いただけます。
- 定性的分析（市場ダイナミクス、促進要因、機会、阻害要因、課題を含む）、コスト構造、OTC医薬品と栄養補助食品価格上昇の影響、最近の動向をご覧いただけます。

本レポートには、COVID-19が業界と貴社にどのような影響を与えるかについてのデータ分析と貴重な洞察が含まれている。本レポートでは、COVID-19の4つの回収パターンとその影響、すなわち「V」、「L」、「W」、「U」について論じている。

レポート対象セグメント

カテゴリー別
- 鎮痛剤
- 風邪・咳・インフルエンザ治療薬
- 胃腸薬
- 眼科
- フェミニンケア
- ビタミン・栄養補助食品
- 睡眠補助食品
- イボ取り
- マウスケア製品
- ボタニカル製品
- 禁煙補助剤

剤形別
- 錠剤
- カプセル
- 粉末
- 軟膏
- ソフトカプセル
- 液体
- その他

流通チャネル別
- 薬局
- ビタミン・健康食品店
- オンライン薬局
- 食料品店

製品タイプ別
- ブランド
- ジェネリック

世界市場全体とセグメント別の収益予測に加え、5つの地域と20の主要国市場の収益予測も掲載しています：

北米
- アメリカ
- カナダ

欧州
- ドイツ
- 英国
- フランス
- スペイン
- イタリア
- その他の欧州

アジア太平洋
- 中国
- 日本
- インド
- オーストラリア
- 韓国
- その他のアジア太平洋地域

ラテンアメリカ
- ブラジル
- メキシコ
- その他のラテンアメリカ

MEA
- GCC
- 南アフリカ
- その他のMEA

報告書に掲載されている主要企業
・ Abbott
・ Amway Corporations
・ Bayer
・ Cipla Inc.
・ Dr. Reddy’s Laboratories
・ Glenmark Pharmaceuticals
・ GlaxoSmithKline plc.
・ Herbalife Nutrition
・ Kenvue Inc. (Previously J＆J Services Business Division)
・ Nestle
・ Perrigo Company Inc.
・ Pfizer Inc.
・ Sanofi
・ Sun Pharmaceuticals

2024年から2034年までのOTC医薬品と栄養補助食品市場全体の世界売上高（金額ベース）は、2024年に2,118億米ドルを突破する。2034年まで力強い収益成長を予測している。当調査では、最も大きな可能性を秘めた組織を特定しています。彼らの能力、進歩、商業的展望を発見し、一歩先を行くお手伝いをします。

OTC医薬品と栄養補助食品市場、2024-2034年レポートはどのようにお役に立ちますか？
要約すると、330ページを超えるこのレポートは、以下のような知識を提供する：

- OTC医薬品と栄養補助食品市場の2024年から2034年までの収益予測製品別、エンドユーザー別、世界レベル、地域レベルの各予測を掲載 - 業界の将来性を発見し、投資と収益に最も有利な場所を見つけます。

- 5つの地域と20の主要国市場の2034年までの収益予測 - OTC医薬品と栄養補助食品市場、北米、欧州、アジア太平洋、ラテンアメリカ、MEAの2024年から2034年までの市場予測をご覧ください。また、米国、カナダ、メキシコ、ブラジル、ドイツ、フランス、英国、イタリア、中国、インド、日本、オーストラリアなどの主要国の市場も予測しています。

- 既存企業および市場参入を目指す企業の展望 - OTC医薬品と栄養補助食品市場に関わる主要企業14社の企業プロファイルを含む、2024年から2034年までの市場。

独自の予測による定量的・定性的分析をご覧ください。私たちのレポートだけに含まれる情報を入手し、貴重なビジネスインテリジェンスで情報を得ることができます。

他にはない情報
私たちの新しいレポートがあれば、知識に遅れをとったり、チャンスを逃したりする可能性が低くなります。Visiongainの調査レポートが貴社の調査、分析、意思決定にどのように役立つかをご覧ください。Visiongainの調査は、OTC医薬品と栄養補助食品市場、2024年～2034年、市場をリードする企業の商業分析を必要とするすべての人のためのものです。データ、トレンド、予測をご覧いただけます。

ページTOPに戻る

1 レポート概要
1.1 研究の目的
1.2 OTC医薬品＆健康補助食品の紹介
1.3 本レポートの内容
1.4 本レポートを読むべき理由
1.5 本分析レポートが回答する主な質問
1.6 本レポートの対象者
1.7 方法論
1.7.1 市場の定義
1.7.2 市場評価・予測手法
1.7.3 データの検証
1.7.3.1 一次調査
1.7.3.2 セカンダリーリサーチ
1.8 よくある質問（FAQ）
1.9 Visiongainの関連レポート
1.10 Visiongainについて

2 エグゼクティブサマリー

3 市場概要
3.1 主要な調査結果
3.2 市場ダイナミクス
3.2.1 市場牽引要因
3.2.1.1 製薬会社のRx薬からOTC薬への切り替え
3.2.1.2 代謝性疾患の有病率の増加
3.2.1.3 セルフメディケーションの増加傾向
3.2.1.4 栄養補助食品に対する意識の高まり
3.2.2 市場抑制要因
3.2.2.1 誤った診断や薬物乱用に関するいくつかの懸念
3.2.2.2 厳しい規制環境
3.2.3 市場機会
3.2.3.1 予防医療ソリューションに対する需要の増加
3.2.3.2 天然有機製品への嗜好の高まり
3.3 COVID-19の影響分析
3.4 ポーターのファイブフォース分析
3.4.1 サプライヤーの交渉力
3.4.2 買い手の交渉力
3.4.3 競争相手のライバル関係
3.4.4 代替品による脅威
3.4.5 新規参入企業の脅威
3.5 PEST分析

4 OTC医薬品と栄養補助食品分析：カテゴリー別
4.1 主要な調査結果
4.2 適応症セグメント市場魅力度指数
4.3 OTC医薬品と栄養補助食品のカテゴリー別市場規模の推定と予測
4.4 鎮痛薬
4.4.1 2024〜2034年の地域別市場規模（US$ Billion）
4.4.2 地域別市場シェア、2024年・2034年 (%)
4.5 風邪薬、咳止め薬、インフルエンザ薬
4.5.1 2024〜2034年の地域別市場規模（US$ Billion）
4.5.2 地域別市場シェア、2024年・2034年 (%)
4.6 消化器関連製品
4.6.1 2024〜2034年の地域別市場規模（US$ Billion）
4.6.2 地域別市場シェア、2024年・2034年 (%)
4.7 眼科用剤
4.7.1 2024〜2034年の地域別市場規模（US$ Billion）
4.7.2 地域別市場シェア、2024年・2034年 (%)
4.8 フェミニンケア
4.8.1 2024〜2034年の地域別市場規模（US$ Billion）
4.8.2 地域別市場シェア、2024年・2034年(%)
4.9 ビタミン・栄養補助食品
4.9.1 2024〜2034年の地域別市場規模（US$ Billion）
4.9.2 地域別市場シェア、2024年・2034年(%)
4.10 睡眠補助剤
4.10.1 2024〜2034年の地域別市場規模（US$ Billion）
4.10.2 地域別市場シェア、2024年・2034年 (%)
4.11 イボ取り剤
4.11.1 2024〜2034年の地域別市場規模（US$ Billion）
4.11.2 地域別市場シェア、2024年・2034年(%)
4.12 マウスケア製品
4.12.1 2024〜2034年の地域別市場規模（US$ Billion）
4.12.2 地域別市場シェア、2024年・2034年 (%)
4.13 植物薬
4.13.1 2024〜2034年の地域別市場規模（US$ Billion）
4.13.2 地域別市場シェア、2024年・2034年 (%)
4.14 禁煙関連製品
4.14.1 2024〜2034年の地域別市場規模（US$ Billion）
4.14.2 地域別市場シェア、2024年・2034年 (%)

5 OTC医薬品と栄養補助食品分析：剤形別
5.1 主要な調査結果
5.2 剤形セグメント市場魅力度指数
5.3 OTC医薬品と栄養補助食品の剤形別市場規模の推定と予測
5.4 錠剤
5.4.1 2024〜2034年の地域別市場規模（US$ Billion）
5.4.2 地域別市場シェア、2024年・2034年(%)
5.5 カプセル
5.5.1 2024〜2034年の地域別市場規模（US$ Billion）
5.5.2 地域別市場シェア、2024年・2034年(%)
5.6 粉末
5.6.1 2024〜2034年の地域別市場規模（US$ Billion）
5.6.2 地域別市場シェア、2024年・2034年(%)
5.7 軟膏
5.7.1 2024〜2034年の地域別市場規模（US$ Billion）
5.7.2 地域別市場シェア、2024年・2034年(%)
5.8 ソフトカプセル
5.8.1 2024〜2034年の地域別市場規模（US$ Billion）
5.8.2 地域別市場シェア、2024年・2034年(%)
5.9 液体
5.9.1 2024〜2034年の地域別市場規模（US$ Billion）
5.9.2 地域別市場シェア、2024年・2034年(%)
5.10 その他
5.10.1 2024〜2034年の地域別市場規模（US$ Billion）
5.10.2 地域別市場シェア、2024年・2034年(%)

6 OTC医薬品と栄養補助食品分析：流通チャネル別
6.1 主な調査結果
6.2 流通チャネルセグメント市場魅力度指数
6.3 OTC医薬品と栄養補助食品の流通チャネル別市場規模推定と予測
6.4 薬局
6.4.1 2024〜2034年の地域別市場規模（US$ Billion）
6.4.2 地域別市場シェア、2024年・2034年(%)
6.5 ビタミン・健康食品店
6.5.1 2024〜2034年の地域別市場規模（US$ Billion）
6.5.2 地域別市場シェア、2024年・2034年(%)
6.6 オンライン薬局
6.6.1 2024〜2034年の地域別市場規模（US$ Billion）
6.6.2 地域別市場シェア、2024年・2034年(%)
6.7 食料品店
6.7.1 2024〜2034年の地域別市場規模（US$ Billion）
6.7.2 地域別市場シェア、2024年・2034年(%)

7 OTC医薬品と栄養補助食品分析：製品タイプ別
7.1 主要な調査結果
7.2 製品タイプ別セグメント市場魅力度指数
7.3 OTC医薬品と栄養補助食品の製品タイプ別市場規模推定と予測
7.4 ブランド
7.4.1 2024〜2034年の地域別市場規模（US$ Billion）
7.4.2 地域別市場シェア、2024年・2034年(%)
7.5 ジェネリック
7.5.1 2024〜2034年の地域別市場規模（US$ Billion）
7.5.2 地域別市場シェア、2024年・2034年(%)

8 OTC医薬品と栄養補助食品分析：地域別
8.1 主要な調査結果
8.2 地域別市場規模の推定と予測

9 北米のOTC医薬品と栄養補助食品分析
9.1 主要調査結果
9.2 北米のOTC医薬品と栄養補助食品魅力度指数
9.3 北米のOTC医薬品と栄養補助食品：国別、2024年、2029年、2034年（US$ Billion）
9.4 北米のOTC医薬品と栄養補助食品市場規模推定と予測：国別
9.5 北米のOTC医薬品と栄養補助食品市場規模推定と予測：カテゴリー別
9.6 北米のOTC医薬品と栄養補助食品市場規模推定と予測：剤形別
9.7 北米のOTC医薬品と栄養補助食品市場規模推定と予測：流通経路別
9.8 北米のOTC医薬品と栄養補助食品市場規模推定と予測：製品タイプ別
9.9 米国のOTC医薬品と栄養補助食品分析
9.10 カナダのOTC医薬品と栄養補助食品分析

10 欧州のOTC医薬品と栄養補助食品分析
10.1 主要な調査結果
10.2 欧州のOTC医薬品と栄養補助食品魅力度指数
10.3 欧州のOTC医薬品と栄養補助食品：国別、2024年、2029年、2034年 (US$10億)
10.4 欧州のOTC医薬品と栄養補助食品市場規模推定と予測：国別
10.5 欧州のOTC医薬品と栄養補助食品市場規模推定と予測：カテゴリー別
10.6 欧州のOTC医薬品と栄養補助食品市場規模推定と予測：剤形別
10.7 欧州のOTC医薬品と栄養補助食品市場規模推定と予測：流通経路別
10.8 欧州のOTC医薬品と栄養補助食品市場規模推定と予測：製品タイプ別
10.9 ドイツのOTC医薬品と栄養補助食品分析
10.10 フランスのOTC医薬品と栄養補助食品分析
10.11 イギリスのOTC医薬品と栄養補助食品分析
10.12 イタリアのOTC医薬品と栄養補助食品分析
10.13 スペインのOTC医薬品と栄養補助食品分析
10.14 ロシアのOTC医薬品と栄養補助食品分析
10.15 その他の欧州のOTC医薬品と栄養補助食品分析

11 アジア太平洋地域のOTC医薬品と栄養補助食品分析
11.1 主要な調査結果
11.2 アジア太平洋地域のOTC医薬品と栄養補助食品魅力度指数
11.3 アジア太平洋地域のOTC医薬品と栄養補助食品：国別、2024年、2029年、2034年（US$ Billion）
11.4 アジア太平洋地域のOTC医薬品と栄養補助食品市場規模推定と予測：国別
11.5 アジア太平洋地域のOTC医薬品と栄養補助食品市場規模推定と予測：カテゴリー別
11.6 アジア太平洋地域のOTC医薬品と栄養補助食品市場規模推定と予測：剤形別
11.7 アジア太平洋地域のOTC医薬品と栄養補助食品市場規模推定と予測：流通経路別
11.8 アジア太平洋地域のOTC医薬品と栄養補助食品市場規模推定と予測：製品タイプ別
11.9 日本のOTC医薬品と栄養補助食品分析
11.10 中国のOTC医薬品と栄養補助食品分析
11.11 インドのOTC医薬品と栄養補助食品分析
11.12 オーストラリアのOTC医薬品と栄養補助食品分析
11.13 韓国のOTC医薬品と栄養補助食品分析
11.14 その他のアジア太平洋地域OTC医薬品と栄養補助食品分析

12 ラテンアメリカのOTC医薬品と栄養補助食品分析
12.1 主要な調査結果
12.2 ラテンアメリカのOTC医薬品と栄養補助食品魅力度指数
12.3 ラテンアメリカのOTC医薬品と栄養補助食品：国別、2024年、2029年、2034年（US$ Billion）
12.4 ラテンアメリカのOTC医薬品と栄養補助食品市場規模推定と予測：国別
12.5 ラテンアメリカのOTC医薬品と栄養補助食品市場規模推定と予測：カテゴリー別
12.6 ラテンアメリカのOTC医薬品と栄養補助食品市場規模推定と予測：剤形別
12.7 ラテンアメリカのOTC医薬品と栄養補助食品市場規模推定と予測：流通経路別
12.8 ラテンアメリカのOTC医薬品と栄養補助食品市場規模推定と予測：製品タイプ別
12.9 ブラジルのOTC医薬品と栄養補助食品分析
12.10 メキシコののOTC医薬品と栄養補助食品分析
12.11 その他のラテンアメリカ地域のOTC医薬品と栄養補助食品分析

13 MEAのOTC医薬品と栄養補助食品分析
13.1 主要な調査結果
13.2 MEAのOTC医薬品と栄養補助食品魅力度指数
13.3 MEAのOTC医薬品と栄養補助食品：国別、2024年、2029年、2034年（US$ Billion）
13.4 MEAのOTC医薬品と栄養補助食品市場規模推定と予測：国別
13.5 MEAのOTC医薬品と栄養補助食品市場規模推定と予測：カテゴリー別
13.6 MEAのOTC医薬品と栄養補助食品市場規模推定と予測：剤形別
13.7 MEAのOTC医薬品と栄養補助食品市場規模推定と予測：流通経路別
13.8 MEAのOTC医薬品と栄養補助食品市場規模推定と予測：製品タイプ別
13.9 GCCのOTC医薬品と栄養補助食品分析
13.10 南アフリカのOTC医薬品と栄養補助食品分析
13.11 その他のMEA地域のOTC医薬品と栄養補助食品分析

14 主要企業のプロファイル
14.1 競争環境、2023年
14.2 戦略的展望
14.3 Abbott
14.3.1 会社概要
14.3.2 会社概要
14.3.3 財務分析
14.3.3.1 純収入、2017-2022年
14.3.3.2 売上高、2017-2022年
14.3.4 製品ベンチマーク
14.3.5 戦略的展望
14.4 Amway Corporation
14.4.1 会社概要
14.4.2 会社概要
14.4.3 財務分析
14.4.3.1 純収入、2017-2022年
14.4.4 製品ベンチマーク
14.4.5 戦略的展望
14.5 Bayer AG
14.5.1 会社概要
14.5.2 会社概要
14.5.3 財務分析
14.5.3.1 純収入、2017-2022年
14.5.3.2 売上高、2017-2022年
14.5.3.3 地域市場シェア、2022年
14.5.4 製品ベンチマーク
14.5.5 戦略的展望
14.6 Cipla, Inc.
14.6.1 会社概要
14.6.2 会社概要
14.6.3 財務分析
14.6.3.1 純収入、2017-2022年
14.6.3.2 地域市場シェア、2022年
14.6.4 製品ベンチマーク
14.6.5 戦略的展望
14.7 Dr. Reddy’s Laboratories Ltd.
14.7.1 会社概要
14.7.2 会社概要
14.7.3 財務分析
14.7.3.1 純収入、2017-2022年
14.7.3.2 R＆D、2017-2022年
14.7.3.3 地域市場シェア、2022年
14.7.4 製品ベンチマーク
14.7.5 戦略的展望
14.8 Glenmark Pharmaceuticals Ltd
14.8.1 会社概要
14.8.2 会社概要
14.8.3 財務分析
14.8.3.1 純収入、2017-2022年
14.8.3.2 地域市場シェア、2022年
14.8.4 製品ベンチマーク
14.8.5 戦略的展望
14.9 GlaxoSmithKline plc
14.9.1 会社概要
14.9.2 会社概要
14.9.3 財務分析
14.9.3.1 純収入、2017-2022年
14.9.3.2 R＆D、2017年〜2022年
14.9.3.3 地域市場シェア、2022年
14.9.4 製品ベンチマーク
14.9.5 戦略的展望
14.10 Herbalife Nutrition
14.10.1 会社概要
14.10.2 会社概要
14.10.3 財務分析
14.10.3.1 純収入、2017-2022年
14.10.3.2 地域市場シェア、2022年
14.10.4 製品ベンチマーク
14.10.5 戦略的展望
14.11 Kenvue Inc. (Previously J & J Services Business Division)
14.11.1 会社概要
14.11.2 会社概要
14.11.3 財務分析
14.11.3.1 純収入、2017-2022年
14.11.3.2 R＆D（2017年～2022年
14.11.3.3 地域市場シェア、2022年
14.11.4 製品ベンチマーク
14.11.5 戦略的展望
14.12 Nestle SA
14.12.1 会社概要
14.12.2 会社概要
14.12.3 財務分析
14.12.3.1 純収入、2017-2022年
14.12.3.2 R＆D、2017-2022年
14.12.3.3 地域市場シェア、2022年
14.12.4 製品ベンチマーク
14.12.5 戦略的展望
14.13 Perrigo Company Inc,
14.13.1 会社概要
14.13.2 会社概要
14.13.3 財務分析
14.13.3.1 純収入、2017-2022年
14.13.3.2 R＆D、2017年～2022年
14.13.3.3 地域市場シェア、2022年
14.13.4 製品ベンチマーク
14.13.5 戦略的展望
14.14 Pfizer Inc.
14.14.1 会社概要
14.14.2 会社概要
14.14.3 財務分析
14.14.3.1 純収入、2017-2022年
14.14.3.2 R＆D、2017-2022年
14.14.3.3 地域市場シェア、2022年
14.14.4 製品ベンチマーク
14.14.5 戦略的展望
14.15 Sanofi
14.15.1 会社概要
14.15.2 会社概要
14.15.3 財務分析
14.15.3.1 純収入、2017-2022年
14.15.3.2 売上高、2017-2022年
14.15.4 製品ベンチマーク
14.15.5 戦略的展望
14.16 Sun Pharmaceutical Industries Ltd
14.16.1 会社概要
14.16.2 会社概要
14.16.3 財務分析
14.16.3.1 純収入、2017-2022年
14.16.3.2 地域市場シェア、2022年
14.16.4 製品ベンチマーク
14.16.5 戦略的展望

15 結論と提言
15.1 Visiongainからの結びの言葉
15.2 市場プレイヤーへの提言

ページTOPに戻る

図表リスト

表の一覧
Table 1 OTC Drugs & Dietary Supplements Snapshot, 2024 & 2034 (US$ Billion, CAGR %)
Table 2 OTC Drugs & Dietary Supplements Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%): “V” Shaped Recovery
Table 3 OTC Drugs & Dietary Supplements Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%): “U” Shaped Recovery
Table 4 OTC Drugs & Dietary Supplements Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%): “W” Shaped Recovery
Table 5 OTC Drugs & Dietary Supplements Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%): “L” Shaped Recovery
Table 6 OTC Drugs & Dietary Supplements Forecast by Categories, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 7 Analgesics Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 8 Cold, Cough and Flu Products Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 9 Gastrointestinal Products Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 10 Ophthalmic Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 11 Feminine Care Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 12 Vitamin and Dietary Supplements Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 13 Sleep Aids Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 14 Wart Removers Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 15 Mouth Care Products Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 16 Botanicals Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 17 Smoking Cessation Products Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 18 OTC Drugs & Dietary Supplements Forecast by Dosage Forms, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 19 Tablets Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 20 Capsules Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 21 Powder Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 22 Ointments Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 23 Soft Capsules Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 24 Liquids Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 25 Others Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 26 OTC Drugs & Dietary Supplements Distribution Channel, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 27 Pharmacies Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 28 Vitamin & Health Food Store Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 29 Online Pharmacy Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 30 Grocery Stores Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 31 OTC Drugs & Dietary Supplements Product Type, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 32 Branded Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 33 Generic Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 34 OTC Drugs & Dietary Supplements Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 35 North America OTC Drugs & Dietary Supplements Forecast by Country, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 36 OTC Drugs & Dietary Supplements Forecast by Categories, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 37 North America OTC Drugs & Dietary Supplements Forecast by Dosage Forms, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 38 OTC Drugs & Dietary Supplements Distribution Channel, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 39 North America OTC Drugs & Dietary Supplements Product Type, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 40 U.S. OTC Drugs & Dietary Supplements Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 41 Canada OTC Drugs & Dietary Supplements Forecast, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 42 Europe OTC Drugs & Dietary Supplements Forecast by Country, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 43 Europe OTC Drugs & Dietary Supplements Forecast by Categories, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 44 Europe OTC Drugs & Dietary Supplements Forecast by Dosage Forms, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 45 OTC Drugs & Dietary Supplements Distribution Channel, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 46 Europe OTC Drugs & Dietary Supplements Product Type, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 47 Germany OTC Drugs & Dietary Supplements Forecast, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 48 France OTC Drugs & Dietary Supplements Forecast, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 49 UK OTC Drugs & Dietary Supplements Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 50 Italy OTC Drugs & Dietary Supplements Forecast, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 51 Spain OTC Drugs & Dietary Supplements Forecast, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 52 Russia OTC Drugs & Dietary Supplements Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 53 Rest of Europe OTC Drugs & Dietary Supplements Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 54 Asia Pacific OTC Drugs & Dietary Supplements Forecast by Country, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 55 Asia Pacific OTC Drugs & Dietary Supplements Forecast by Categories, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 56 OTC Drugs & Dietary Supplements Forecast by Dosage Forms, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 57 OTC Drugs & Dietary Supplements Distribution Channel, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 58 Asia Pacific OTC Drugs & Dietary Supplements Product Type, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 59 Japan OTC Drugs & Dietary Supplements Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 60 China OTC Drugs & Dietary Supplements Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 61 India OTC Drugs & Dietary Supplements Forecast, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 62 Australia OTC Drugs & Dietary Supplements Forecast, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 63 South Korea OTC Drugs & Dietary Supplements Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 64 Rest of Asia Pacific OTC Drugs & Dietary Supplements Forecast, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 65 Latin America OTC Drugs & Dietary Supplements Forecast by Country, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 66 OTC Drugs & Dietary Supplements Forecast by Categories, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 67 OTC Drugs & Dietary Supplements Forecast by Dosage Forms, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 68 OTC Drugs & Dietary Supplements Distribution Channel, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 69 Latin America OTC Drugs & Dietary Supplements Product Type, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 70 Brazil OTC Drugs & Dietary Supplements Forecast, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 71 Mexico OTC Drugs & Dietary Supplements Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 72 Rest of Latin America OTC Drugs & Dietary Supplements Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 73 MEA OTC Drugs & Dietary Supplements Forecast by Country, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 74 OTC Drugs & Dietary Supplements Forecast by Categories, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 75 OTC Drugs & Dietary Supplements Forecast by Dosage Forms, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 76 OTC Drugs & Dietary Supplements Distribution Channel, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 77 MEA OTC Drugs & Dietary Supplements Product Type, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 78 GCC OTC Drugs & Dietary Supplements Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 79 South Africa OTC Drugs & Dietary Supplements Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 80 Rest of MEA OTC Drugs & Dietary Supplements Forecast, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 81 Strategic Outlook
Table 82 Abbott: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 83 Abbott: Product Benchmarking
Table 84 Abbott: Strategic Outlook
Table 85 Amway Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 86 Amway Corporation: Product Benchmarking
Table 87 Amway Corporation: Strategic Outlook
Table 88 Bayer AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 89 Bayer AG: Product Benchmarking
Table 90 Bayer AG: Strategic Outlook
Table 91 Cipla, Inc. Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 92 Cipla, Inc.: Product Benchmarking
Table 93 Cipla, Inc.: Strategic Outlook
Table 94 Dr. Reddy’s Laboratories Ltd: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 95 Dr. Reddy’s Laboratories Ltd: Product Benchmarking
Table 96 Dr. Reddy’s Laboratories Ltd: Strategic Outlook
Table 97 Glenmark Pharmaceuticals Ltd: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 98 Glenmark Pharmaceuticals Ltd: Product Benchmarking
Table 99 Glenmark Pharmaceuticals Ltd: Strategic Outlook
Table 100 GlaxoSmithKline plc; Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 101 GlaxoSmithKline plc: Product Benchmarking
Table 102 GlaxoSmithKline plc: Strategic Outlook
Table 103 Herbalife Nutrition: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 104 Herbalife Nutrition: Product Benchmarking
Table 105 Herbalife Nutrition: Strategic Outlook
Table 106 Kenvue Inc. (Previously J & J Services Business Division).: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 107 Kenvue Inc. (Previously J & J Services Business Division): Product Benchmarking
Table 108 Kenvue Inc. (Previously J & J Services Business Division): Strategic Outlook
Table 109 Nestle SA: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 110 Nestle SA: Product Benchmarking
Table 111 Nestle SA: Strategic Outlook
Table 112 Perrigo Company Inc, Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 113 Perrigo Company Inc, Product Benchmarking
Table 114 Perrigo Company Inc, Strategic Outlook
Table 115 Pfizer Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 116 Pfizer Inc.: Product Benchmarking
Table 117 Pfizer Inc.: Strategic Outlook
Table 118 Sanofi: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 119 Sanofi: Product Benchmarking
Table 120 Sanofi: Strategic Outlook
Table 121 Sun Pharmaceutical Industries Ltd: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 122 Sun Pharmaceutical Industries Ltd: Product Benchmarking
Table 123 Sun Pharmaceutical Industries Ltd: Strategic Outlook

図の一覧
Figure 1 OTC Drugs & Dietary Supplements Segmentation
Figure 2 OTC Drugs & Dietary Supplements Market by Categories: Market Attractiveness Index
Figure 3 OTC Drugs & Dietary Supplements by Dosage Forms: Market Attractiveness Index
Figure 4 OTC Drugs & Dietary Supplements by Distribution Channel: Market Attractiveness Index
Figure 5 OTC Drugs & Dietary Supplements by Product Type: Market Attractiveness Index
Figure 6 OTC Drugs & Dietary Supplements Attractiveness Index by Region
Figure 7 OTC Drugs & Dietary Supplements: Market Dynamics
Figure 8 OTC Drugs & Dietary Supplements by Region, 2024-2034 (US$ Billion, AGR %): “V” Shaped Recovery
Figure 9 OTC Drugs & Dietary Supplements by Region, 2024-2034 (US$ Billion, AGR %): “U” Shaped Recovery
Figure 10 OTC Drugs & Dietary Supplements by Region, 2024-2034 (US$ Billion, AGR %): “W” Shaped Recovery
Figure 11 OTC Drugs & Dietary Supplements by Region, 2024-2034 (US$ Billion, AGR %): “L” Shaped Recovery
Figure 12 OTC Drugs & Dietary Supplements Market: Porter’s Five Forces Analysis
Figure 13 OTC Drugs & Dietary Supplements: PEST Analysis
Figure 14 OTC Drugs & Dietary Supplements by Categories: Market Attractiveness Index
Figure 15 OTC Drugs & Dietary Supplements Forecast by Categories, 2024-2034 (US$ Billion, AGR %)
Figure 16 OTC Drugs & Dietary Supplements Share Forecast by Categories, 2024, 2029, 2034 (%)
Figure 17 Analgesics Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 18 Analgesics Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 19 Cold, Cough and Flu Products Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 20 Cold, Cough and Flu Products Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 21 Gastrointestinal Products Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 22 Gastrointestinal Products Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 23 Ophthalmic Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 24 Ophthalmic Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 25 Feminine Care Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 26 Feminine Care Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 27 Vitamin and Dietary Supplements Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 28 Vitamin and Dietary Supplements Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 29 Sleep Aids Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 30 Sleep Aids Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 31 Wart Removers Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 32 Wart Removers Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 33 Mouth Care Products Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 34 Mouth Care Products Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 35 Botanicals Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 36 Botanicals Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 37 Smoking Cessation Products Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 38 Smoking Cessation Products Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 39 OTC Drugs & Dietary Supplements by Dosage Forms: Market Attractiveness Index
Figure 40 OTC Drugs & Dietary Supplements Forecast by Dosage Forms, 2024-2034 (US$ Billion, AGR %)
Figure 41 OTC Drugs & Dietary Supplements Share Forecast by Dosage Forms, 2024, 2029, 2034 (%)
Figure 42 Tablets Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 43 Tablets Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 44 Capsules Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 45 Capsules Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 46 Powder Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 47 Powder Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 48 Ointments Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 49 Ointments Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 50 Soft Capsules Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 51 Soft Capsules Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 52 Liquids Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 53 Liquids Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 54 Others Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 55 Others Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 56 OTC Drugs & Dietary Supplements by Distribution Channel: Market Attractiveness Index
Figure 57 OTC Drugs & Dietary Supplements Forecast by Distribution Channel, 2024-2034 (US$ Billion, AGR %)
Figure 58 Active Pharmaceutical Ingredients Market Share Forecast by Distribution Channel, 2024, 2029, 2034 (%)
Figure 59 Pharmacies Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 60 Pharmacies Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 61 Vitamin & Health Food Store Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 62 Vitamin & Health Food Store Market Share Forecast by Region, 2024 & 2034 (%)
Figure 63 Online Pharmacy Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 64 Online Pharmacy Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 65 Grocery Stores Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 66 Grocery Stores Market Share Forecast by Region, 2024 & 2034 (%)
Figure 67 OTC Drugs & Dietary Supplements by Product Type: Market Attractiveness Index
Figure 68 OTC Drugs & Dietary Supplements Forecast by Product Type, 2024-2034 (US$ Billion, AGR %)
Figure 69 OTC Drugs & Dietary Supplements Share Forecast by Product Type, 2024, 2029, 2034 (%)
Figure 70 Branded Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 71 Branded Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 72 Generic Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 73 Generic Market Share Forecast by Region, 2024 & 2034 (%)
Figure 74 OTC Drugs & Dietary Supplements Forecast by Region 2023 and 2033 (Revenue, CAGR %)
Figure 75 Active Pharmaceutical Ingredients Market Share Forecast by Region 2024, 2029, 2034 (%)
Figure 76 OTC Drugs & Dietary Supplements by Region, 2024-2034 (US$ Billion, AGR %)
Figure 77 North America OTC Drugs & Dietary Supplements Attractiveness Index
Figure 78 North America OTC Drugs & Dietary Supplements by Region, 2024, 2029 & 2034 (US$ Billion)
Figure 79 North America OTC Drugs & Dietary Supplements Forecast by Country, 2024-2034 (US$ Billion, AGR %)
Figure 80 North America OTC Drugs & Dietary Supplements Share Forecast by Country, 2024 & 2034 (%)
Figure 81 North America OTC Drugs & Dietary Supplements Forecast by Categories, 2024-2034 (US$ Billion, AGR %)
Figure 82 North America OTC Drugs & Dietary Supplements Share Forecast by Categories, 2024 & 2034 (%)
Figure 83 North America OTC Drugs & Dietary Supplements Forecast by Dosage Forms, 2024-2034 (US$ Billion, AGR %)
Figure 84 North America OTC Drugs & Dietary Supplements Share Forecast by Dosage Forms, 2024 & 2034 (%)
Figure 85 North America OTC Drugs & Dietary Supplements Forecast by Distribution Channel, 2024-2034 (US$ Billion, AGR %)
Figure 86 North America OTC Drugs & Dietary Supplements Share Forecast by Distribution Channel, 2024 & 2034 (%)
Figure 87 North America OTC Drugs & Dietary Supplements Forecast by Product Type, 2024-2034 (US$ Billion, AGR %)
Figure 88 North America OTC Drugs & Dietary Supplements Share Forecast by Product Type, 2024 & 2034 (%)
Figure 89 U.S. OTC Drugs & Dietary Supplements Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 90 Canada OTC Drugs & Dietary Supplements Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 91 Europe OTC Drugs & Dietary Supplements Attractiveness Index
Figure 92 Europe OTC Drugs & Dietary Supplements by Region, 2024, 2029 & 2034 (US$ Billion)
Figure 93 Europe OTC Drugs & Dietary Supplements Forecast by Country, 2024-2034 (US$ Billion, AGR %)
Figure 94 Europe OTC Drugs & Dietary Supplements Share Forecast by Country, 2024 & 2034 (%)
Figure 95 Europe OTC Drugs & Dietary Supplements Forecast by Categories, 2024-2034 (US$ Billion, AGR %)
Figure 96 Europe OTC Drugs & Dietary Supplements Share Forecast by Categories, 2024 & 2034 (%)
Figure 97 Europe OTC Drugs & Dietary Supplements Forecast by Dosage Forms, 2024-2034 (US$ Billion, AGR %)
Figure 98 Europe OTC Drugs & Dietary Supplements Share Forecast by Dosage Forms, 2024 & 2034 (%)
Figure 99 Europe OTC Drugs & Dietary Supplements Forecast by Distribution Channel, 2024-2034 (US$ Billion, AGR %)
Figure 100 Europe OTC Drugs & Dietary Supplements Share Forecast by Distribution Channel, 2024 & 2034 (%)
Figure 101 Europe OTC Drugs & Dietary Supplements Forecast by Product Type, 2024-2034 (US$ Billion, AGR %)
Figure 102 Europe OTC Drugs & Dietary Supplements Share Forecast by Product Type, 2024 & 2034 (%)
Figure 103 Germany OTC Drugs & Dietary Supplements Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 104 France OTC Drugs & Dietary Supplements Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 105 UK OTC Drugs & Dietary Supplements Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 106 Italy OTC Drugs & Dietary Supplements Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 107 Spain OTC Drugs & Dietary Supplements Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 108 Russia OTC Drugs & Dietary Supplements Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 109 Rest of Europe OTC Drugs & Dietary Supplements Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 110 Asia Pacific OTC Drugs & Dietary Supplements Attractiveness Index
Figure 111 Asia Pacific OTC Drugs & Dietary Supplements by Region, 2024, 2029 & 2034 (US$ Billion)
Figure 112 Asia Pacific OTC Drugs & Dietary Supplements Forecast by Country, 2024-2034 (US$ Billion, AGR %)
Figure 113 Asia Pacific OTC Drugs & Dietary Supplements Share Forecast by Country, 2024 & 2034 (%)
Figure 114 Asia Pacific OTC Drugs & Dietary Supplements Forecast by Categories, 2024-2034 (US$ Billion, AGR %)
Figure 115 Asia Pacific OTC Drugs & Dietary Supplements Share Forecast by Categories, 2024 & 2034 (%)
Figure 116 Asia Pacific OTC Drugs & Dietary Supplements Forecast by Dosage Forms, 2024-2034 (US$ Billion, AGR %)
Figure 117 Asia Pacific OTC Drugs & Dietary Supplements Share Forecast by Dosage Forms, 2024 & 2034 (%)
Figure 118 Asia Pacific OTC Drugs & Dietary Supplements Forecast by Distribution Channel, 2024-2034 (US$ Billion, AGR %)
Figure 119 Asia Pacific OTC Drugs & Dietary Supplements Share Forecast by Distribution Channel, 2024 & 2034 (%)
Figure 120 Asia Pacific OTC Drugs & Dietary Supplements Forecast by Product Type, 2024-2034 (US$ Billion, AGR %)
Figure 121 Asia Pacific OTC Drugs & Dietary Supplements Share Forecast by Product Type, 2024 & 2034 (%)
Figure 122 Japan OTC Drugs & Dietary Supplements Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 123 China OTC Drugs & Dietary Supplements Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 124 India OTC Drugs & Dietary Supplements Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 125 Australia OTC Drugs & Dietary Supplements Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 126 South Korea OTC Drugs & Dietary Supplements Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 127 Rest of Asia Pacific OTC Drugs & Dietary Supplements Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 128 Latin America OTC Drugs & Dietary Supplements Attractiveness Index
Figure 129 Latin America OTC Drugs & Dietary Supplements by Region, 2024, 2029 & 2034 (US$ Billion)
Figure 130 Latin America OTC Drugs & Dietary Supplements Forecast by Country, 2024-2034 (US$ Billion, AGR %)
Figure 131 Latin America OTC Drugs & Dietary Supplements Share Forecast by Country, 2024 & 2034 (%)
Figure 132 Latin America OTC Drugs & Dietary Supplements Forecast by Categories, 2024-2034 (US$ Billion, AGR %)
Figure 133 Latin America OTC Drugs & Dietary Supplements Share Forecast by Categories, 2024 & 2034 (%)
Figure 134 Latin America OTC Drugs & Dietary Supplements Forecast by Dosage Forms, 2024-2034 (US$ Billion, AGR %)
Figure 135 Latin America OTC Drugs & Dietary Supplements Share Forecast by Dosage Forms, 2024 & 2034 (%)
Figure 136 Latin America OTC Drugs & Dietary Supplements Forecast by Distribution Channel, 2024-2034 (US$ Billion, AGR %)
Figure 137 Latin America OTC Drugs & Dietary Supplements Share Forecast by Distribution Channel, 2024 & 2034 (%)
Figure 138 Latin America OTC Drugs & Dietary Supplements Forecast by Product Type, 2024-2034 (US$ Billion, AGR %)
Figure 139 Latin America OTC Drugs & Dietary Supplements Share Forecast by Product Type, 2024 & 2034 (%)
Figure 140 Brazil OTC Drugs & Dietary Supplements Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 141 Mexico OTC Drugs & Dietary Supplements Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 142 Rest of Latin America OTC Drugs & Dietary Supplements Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 143 MEA OTC Drugs & Dietary Supplements Attractiveness Index
Figure 144 MEA OTC Drugs & Dietary Supplements by Region, 2024, 2029 & 2034 (US$ Billion)
Figure 145 MEA OTC Drugs & Dietary Supplements Forecast by Country, 2024-2034 (US$ Billion, AGR %)
Figure 146 MEA OTC Drugs & Dietary Supplements Share Forecast by Country, 2024 & 2034 (%)
Figure 147 MEA OTC Drugs & Dietary Supplements Forecast by Categories, 2024-2034 (US$ Billion, AGR %)
Figure 148 MEA OTC Drugs & Dietary Supplements Share Forecast by Categories, 2024 & 2034 (%)
Figure 149 MEA OTC Drugs & Dietary Supplements Forecast by Dosage Forms, 2024-2034 (US$ Billion, AGR %)
Figure 150 MEA OTC Drugs & Dietary Supplements Share Forecast by Dosage Forms, 2024 & 2034 (%)
Figure 151 MEA OTC Drugs & Dietary Supplements Forecast by Distribution Channel, 2024-2034 (US$ Billion, AGR %)
Figure 152 MEA OTC Drugs & Dietary Supplements Share Forecast by Distribution Channel, 2024 & 2034 (%)
Figure 153 MEA OTC Drugs & Dietary Supplements Forecast by Product Type, 2024-2034 (US$ Billion, AGR %)
Figure 154 MEA OTC Drugs & Dietary Supplements Share Forecast by Product Type, 2024 & 2034 (%)
Figure 155 GCC OTC Drugs & Dietary Supplements Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 156 South Africa OTC Drugs & Dietary Supplements Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 157 Rest of MEA OTC Drugs & Dietary Supplements Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 158 OTC Drugs & Dietary Supplements Market: Company Share, 2023
Figure 159 Abbott: Net Revenue, 2017-2022 (US$ Million, AGR %)
Figure 160 Abbott: R&D, 2017-2022 (US$ Million, AGR %)
Figure 161 Amway Corporation: Net Revenue, 2017-2022 (US$ Million, AGR %)
Figure 162 Bayer AG: Net Revenue, 2017-2022 (US$ Million, AGR %)
Figure 163 Bayer AG: R&D, 2017-2022 (US$ Million, AGR%)
Figure 164 Bayer AG: Regional Market Shares, 2022
Figure 165 Cipla, Inc. Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 166 Cipla Inc,. Regional Market Shares, 2022
Figure 167 Dr. Reddy’s Laboratories Ltd: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 168 Dr. Reddy’s Laboratories Ltd: R&D, 2017-2022 (US$ Million, AGR%)
Figure 169 Dr. Reddy’s Laboratories Ltd: Regional Market Shares, 2022
Figure 170 Glenmark Pharmaceuticals Ltd: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 171 Glenmark Pharmaceuticals Ltd: Regional Market Shares, 2022
Figure 172 GlaxoSmithKline plc ; Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 173 GlaxoSmithKline plc; R&D, 2017-2022 (US$ Million, AGR%)
Figure 174 GlaxoSmithKline plc ; Regional Market Shares, 2022
Figure 175 Herbalife Nutrition: Net Revenue, 2017-2022 (US$ Million, AGR %)
Figure 176 Herbalife Nutrition: Regional Market Shares, 2022
Figure 177 Kenvue Inc. (Previously J & J Services Business Division).: Net Revenue, 2017-2022 (US$ Million, AGR %)
Figure 178 Kenvue Inc. (Previously J & J Services Business Division).: R&D, 2017-2022 (US$ Million, AGR%)
Figure 179 Kenvue Inc. (Previously J & J Services Business Division): Regional Market Shares, 2022
Figure 180 Nestle SA: Net Revenue, 2017-2022 (US$ Million, AGR %)
Figure 181 Nestle SA: R&D, 2017-2022 (US$ Million, AGR %)
Figure 182 Nestle SA: Regional Market Shares, 2022
Figure 183 Perrigo Company Inc, Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 184 Perrigo Company Inc, R&D, 2017-2022 (US$ Million, AGR%)
Figure 185 Perrigo Company Inc, Regional Market Shares, 2022
Figure 186 Pfizer Inc.: Net Revenue, 2017-2022 (US$ Million, AGR %)
Figure 187 Pfizer Inc.: R&D, 2017-2022 (US$ Million, AGR %)
Figure 188 Pfizer Inc.: Regional Market Shares, 2022
Figure 189 Sanofi: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 190 Sanofi: R&D, 2017-2022 (US$ Million, AGR%)
Figure 191 Sun Pharmaceutical Industries Ltd: Net Revenue, 2017-2022 (US$ Million, AGR %)
Figure 192 Sun Pharmaceutical Industries Ltd: Regional Market Shares, 2022

ページTOPに戻る

Table of Contents
List of Tables/Graphs

Summary

Report Details

The OTC Drugs & Dietary Supplements Report 2024-2034: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Pharmaceutical companies transitioning from prescription medications to over-the-counter drugs
The traditional model of pharmaceuticals, dominated by prescription medications, is undergoing a transformative phase. Pharmaceutical companies are strategically realigning their focus to cater to the growing demand for OTC drugs and supplements. This transition is driven by various factors, including changing consumer preferences, advancements in self-care awareness, and the potential for expanded market reach. One of the primary impacts of this transition is the increased accessibility of medications for consumers. OTC drugs and supplements empower individuals to take charge of their health, providing a convenient avenue for managing common ailments without the need for a prescription. This shift aligns with a broader global trend towards self-directed healthcare and preventive wellness. As the industry continues to evolve, it is essential to monitor how these changes shape consumer behavior, market dynamics, and regulatory environments. The ongoing transformation signifies a significant milestone in healthcare, emphasizing the importance of empowering individuals in managing their well-being.

Evolving Regulatory Standardizations Will Limit the Growth
One of the key impacts of evolving regulatory bodies is the pursuit of harmonization and standardization. Regulatory agencies globally are working towards aligning standards to ensure consistency in the evaluation and approval processes for OTC drugs and supplements. This move aims to streamline market access, reduce trade barriers, and enhance the overall quality and safety of products available to consumers. Changing regulatory frameworks prioritize consumer safety and confidence by implementing stringent guidelines and monitoring mechanisms. The emphasis on transparency, clear labeling, and comprehensive product information is bolstering consumer trust in OTC products. Regulatory bodies play a pivotal role in ensuring that OTC drugs and supplements meet the highest standards of quality and efficacy. While regulatory changes bring positive outcomes, they also pose challenges for industry players. Adapting to new compliance requirements can be resource-intensive, and companies must navigate the evolving landscape to ensure that their products meet the latest standards. The need for continuous monitoring and adjustment to regulatory changes is a critical aspect of sustaining success in the OTC market. The impact of changing regulatory bodies extends beyond national borders, influencing the global OTC market dynamics. Companies operating in multiple regions must navigate diverse regulatory landscapes, adapting their strategies to comply with varying requirements. This presents both challenges and opportunities as companies strive to create a global presence while adhering to local regulations.

What Questions Should You Ask before Buying a Market Research Report?
• How is the OTC Drugs & Dietary Supplements Market evolving?
• What is driving and restraining the OTC Drugs & Dietary Supplements Market?
• How will each OTC Drugs & Dietary Supplements submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2034?
• How will the market shares for each OTC Drugs & Dietary Supplements submarket develop from 2024 to 2034?
• What will be the main driver for the overall market from 2024 to 2034?
• Will leading OTC Drugs & Dietary Supplements Markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2034?
• Who are the leading players and what are their prospects over the forecast period?
• What are the OTC Drugs & Dietary Supplements projects for these leading companies?
• How will the industry evolve during the period between 2024 and 2034? What are the implications of OTC Drugs & Dietary Supplements projects taking place now and over the next 10 years?
• Is there a greater need for product commercialisation to further scale the OTC Drugs & Dietary Supplements Market?
• Where is the OTC Drugs & Dietary Supplements Market heading and how can you ensure you are at the forefront of the market?
• What are the best investment options for new product and service lines?
• What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the OTC Drugs & Dietary Supplements Market today, and over the next 10 years:
• Our 337-page report provides 123 tables and 192 charts/graphs exclusively to you.
• The report highlights key lucrative areas in the industry so you can target them – NOW.
• It contains in-depth analysis of global, regional and national sales and growth.
• It highlights for you the key successful trends, changes and revenue projections made by your competitors.

This report tells you TODAY how the OTC Drugs & Dietary Supplements Market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2034 and other analyses reveal commercial prospects
• In addition to revenue forecasting to 2034, our new study provides you with recent results, growth rates, and market shares.
• You will find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising OTC Drugs & Dietary Supplements prices and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.

Segments Covered in the Report

By Categories
• Analgesics
• Cold, cough and Flu Products
• Gastrointestinal Products
• Ophthalmic
• Feminine Care
• Vitamin and Dietary Supplements
• Sleep Aids
• Wart Removers
• Mouth Care Products
• Botanicals
• Smoking Cessation Products

By Dosage Forms
• Tablets
• Capsules
• Powder
• Ointments
• Soft Capsules
• Liquids
• Others

By Distribution Channel
• Pharmacies
• Vitamin & Health Food Store
• Online Pharmacy
• Grocery Stores

By Product Type
• Branded
• Generic

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 20 leading national markets:

North America
• U.S.
• Canada

Europe
• Germany
• UK
• France
• Spain
• Italy
• Rest of Europe

Asia Pacific
• China
• Japan
• India
• Australia
• South Korea
• Rest of Asia Pacific

Latin America
• Brazil
• Mexico
• Rest of Latin America

MEA
• GCC
• South Africa
• Rest of MEA

Leading companies profiled in the report
• Abbott
• Amway Corporations
• Bayer
• Cipla Inc.
• Dr. Reddy’s Laboratories
• Glenmark Pharmaceuticals
• GlaxoSmithKline plc.
• Herbalife Nutrition
• Kenvue Inc. (Previously J&J Services Business Division)
• Nestle
• Perrigo Company Inc.
• Pfizer Inc.
• Sanofi
• Sun Pharmaceuticals

Overall world revenue for OTC Drugs & Dietary Supplements Market, 2024 to 2034 in terms of value the market will surpass US$211.8 billion in 2024, our work calculates. We predict strong revenue growth through to 2034. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the OTC Drugs & Dietary Supplements Market, 2024 to 2034 report help you?
In summary, our 330+ page report provides you with the following knowledge:

• Revenue forecasts to 2034 for OTC Drugs & Dietary Supplements Market, 2024 to 2034 Market, with forecasts for product and end-user, each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.

• Revenue forecasts to 2034 for five regional and 20 key national markets – See forecasts for the OTC Drugs & Dietary Supplements Market, 2024 to 2034 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.

• Prospects for established firms and those seeking to enter the market – including company profiles for 14 of the major companies involved in the OTC Drugs & Dietary Supplements Market, 2024 to 2034.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Information found nowhere else
With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the OTC Drugs & Dietary Supplements Market, 2024 to 2034, market-leading companies. You will find data, trends and predictions.

ページTOPに戻る

Table of Contents

1 Report Overview
1.1 Objectives of the Study
1.2 Introduction to OTC Drugs & Dietary Supplements
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report for?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain

2 Executive Summary

3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.2.1 Market Driving Factors
3.2.1.1 Pharmaceutical Companies switching from Rx to OTC Drugs
3.2.1.2 Increasing Prevalence of Metabolic Disorders
3.2.1.3 Growing Trend of Self-Medication
3.2.1.4 Increasing Awareness of Nutraceutical Products
3.2.2 Market Restraining Factors
3.2.2.1 Several concerns pertaining to incorrect diagnosis and substance abuse
3.2.2.2 Challenging regulatory environment
3.2.3 Market Opportunities
3.2.3.1 Increasing Demand for Preventive Healthcare solutions
3.2.3.2 Growing Preference for Natural and Organic Products
3.3 COVID-19 Impact Analysis
3.4 Porter’s Five Forces Analysis
3.4.1 Bargaining Power of Suppliers
3.4.2 Bargaining Power of Buyers
3.4.3 Competitive Rivalry
3.4.4 Threat from Substitutes
3.4.5 Threat of New Entrants
3.5 PEST Analysis

4 OTC Drugs & Dietary Supplements Analysis by Categories
4.1 Key Findings
4.2 Indication Segment: Market Attractiveness Index
4.3 OTC Drugs & Dietary Supplements Size Estimation and Forecast by Categories
4.4 Analgesics
4.4.1 Market Size by Region, 2024-2034 (US$ Billion)
4.4.2 Market Share by Region, 2024 & 2034 (%)
4.5 Cold, Cough and Flu Products
4.5.1 Market Size by Region, 2024-2034 (US$ Billion)
4.5.2 Market Share by Region, 2024 & 2034 (%)
4.6 Gastrointestinal Products
4.6.1 Market Size by Region, 2024-2034 (US$ Billion)
4.6.2 Market Share by Region, 2024 & 2034 (%)
4.7 Ophthalmic
4.7.1 Market Size by Region, 2024-2034 (US$ Billion)
4.7.2 Market Share by Region, 2024 & 2034 (%)
4.8 Feminine Care
4.8.1 Market Size by Region, 2024-2034 (US$ Billion)
4.8.2 Market Share by Region, 2024 & 2034 (%)
4.9 Vitamin and Dietary Supplements
4.9.1 Market Size by Region, 2024-2034 (US$ Billion)
4.9.2 Market Share by Region, 2024 & 2034 (%)
4.10 Sleep Aids
4.10.1 Market Size by Region, 2024-2034 (US$ Billion)
4.10.2 Market Share by Region, 2024 & 2034 (%)
4.11 Wart Removers
4.11.1 Market Size by Region, 2024-2034 (US$ Billion)
4.11.2 Market Share by Region, 2024 & 2034 (%)
4.12 Mouth Care Products
4.12.1 Market Size by Region, 2024-2034 (US$ Billion)
4.12.2 Market Share by Region, 2024 & 2034 (%)
4.13 Botanicals
4.13.1 Market Size by Region, 2024-2034 (US$ Billion)
4.13.2 Market Share by Region, 2024 & 2034 (%)
4.14 Smoking Cessation Products
4.14.1 Market Size by Region, 2024-2034 (US$ Billion)
4.14.2 Market Share by Region, 2024 & 2034 (%)

5 OTC Drugs & Dietary Supplements Analysis by Dosage Forms
5.1 Key Findings
5.2 Dosage Forms Segment: Market Attractiveness Index
5.3 OTC Drugs & Dietary Supplements Size Estimation and Forecast by Dosage Forms
5.4 Tablets
5.4.1 Market Size by Region, 2024-2034 (US$ Billion)
5.4.2 Market Share by Region, 2024 & 2034 (%)
5.5 Capsules
5.5.1 Market Size by Region, 2024-2034 (US$ Billion)
5.5.2 Market Share by Region, 2024 & 2034 (%)
5.6 Powder
5.6.1 Market Size by Region, 2024-2034 (US$ Billion)
5.6.2 Market Share by Region, 2024 & 2034 (%)
5.7 Ointments
5.7.1 Market Size by Region, 2024-2034 (US$ Billion)
5.7.2 Market Share by Region, 2024 & 2034 (%)
5.8 Soft Capsules
5.8.1 Market Size by Region, 2024-2034 (US$ Billion)
5.8.2 Market Share by Region, 2024 & 2034 (%)
5.9 Liquids
5.9.1 Market Size by Region, 2024-2034 (US$ Billion)
5.9.2 Market Share by Region, 2024 & 2034 (%)
5.10 Others
5.10.1 Market Size by Region, 2024-2034 (US$ Billion)
5.10.2 Market Share by Region, 2024 & 2034 (%)

6 OTC Drugs & Dietary Supplements Analysis by Distribution Channel
6.1 Key Findings
6.2 Distribution Channel Segment: Market Attractiveness Index
6.3 OTC Drugs & Dietary Supplements Size Estimation and Forecast by Distribution Channel
6.4 Pharmacies
6.4.1 Market Size by Region, 2024-2034 (US$ Billion)
6.4.2 Market Share by Region, 2024 & 2034 (%)
6.5 Vitamin & Health Food Store
6.5.1 Market Size by Region, 2024-2034 (US$ Billion)
6.5.2 Market Share by Region, 2024 & 2034 (%)
6.6 Online Pharmacy
6.6.1 Market Size by Region, 2024-2034 (US$ Billion)
6.6.2 Market Share by Region, 2024 & 2034 (%)
6.7 Grocery Stores
6.7.1 Market Size by Region, 2024-2034 (US$ Billion)
6.7.2 Market Share by Region, 2024 & 2034 (%)

7 OTC Drugs & Dietary Supplements Analysis by Product Type
7.1 Key Findings
7.2 Product Type Segment: Market Attractiveness Index
7.3 OTC Drugs & Dietary Supplements Size Estimation and Forecast by Product Type
7.4 Branded
7.4.1 Market Size by Region, 2024-2034 (US$ Billion)
7.4.2 Market Share by Region, 2024 & 2034 (%)
7.5 Generic
7.5.1 Market Size by Region, 2024-2034 (US$ Billion)
7.5.2 Market Share by Region, 2024 & 2034 (%)

8 OTC Drugs & Dietary Supplements Analysis by Region
8.1 Key Findings
8.2 Regional Market Size Estimation and Forecast

9 North America OTC Drugs & Dietary Supplements Analysis
9.1 Key Findings
9.2 North America OTC Drugs & Dietary Supplements Attractiveness Index
9.3 North America OTC Drugs & Dietary Supplements by Country, 2024, 2029 & 2034 (US$ Billion)
9.4 North America OTC Drugs & Dietary Supplements Size Estimation and Forecast by Country
9.5 North America OTC Drugs & Dietary Supplements Size Estimation and Forecast by Categories
9.6 North America OTC Drugs & Dietary Supplements Size Estimation and Forecast by Dosage Forms
9.7 North America OTC Drugs & Dietary Supplements Size Estimation and Forecast by Distribution Channel
9.8 North America OTC Drugs & Dietary Supplements Size Estimation and Forecast by Product Type
9.9 U.S. OTC Drugs & Dietary Supplements Analysis
9.10 Canada OTC Drugs & Dietary Supplements Analysis

10 Europe OTC Drugs & Dietary Supplements Analysis
10.1 Key Findings
10.2 Europe OTC Drugs & Dietary Supplements Attractiveness Index
10.3 Europe OTC Drugs & Dietary Supplements by Country, 2024, 2029 & 2034 (US$ Billion)
10.4 Europe OTC Drugs & Dietary Supplements Size Estimation and Forecast by Country
10.5 Europe OTC Drugs & Dietary Supplements Size Estimation and Forecast by Categories
10.6 Europe OTC Drugs & Dietary Supplements Size Estimation and Forecast by Dosage Forms
10.7 Europe OTC Drugs & Dietary Supplements Size Estimation and Forecast by Distribution Channel
10.8 Europe OTC Drugs & Dietary Supplements Size Estimation and Forecast by Product Type
10.9 Germany OTC Drugs & Dietary Supplements Analysis
10.10 France OTC Drugs & Dietary Supplements Analysis
10.11 UK OTC Drugs & Dietary Supplements Analysis
10.12 Italy OTC Drugs & Dietary Supplements Analysis
10.13 Spain OTC Drugs & Dietary Supplements Analysis
10.14 Russia OTC Drugs & Dietary Supplements Analysis
10.15 Rest of Europe OTC Drugs & Dietary Supplements Analysis

11 Asia Pacific OTC Drugs & Dietary Supplements Analysis
11.1 Key Findings
11.2 Asia Pacific OTC Drugs & Dietary Supplements Attractiveness Index
11.3 Asia Pacific OTC Drugs & Dietary Supplements by Country, 2024, 2029 & 2034 (US$ Billion)
11.4 Asia Pacific OTC Drugs & Dietary Supplements Size Estimation and Forecast by Country
11.5 Asia Pacific OTC Drugs & Dietary Supplements Size Estimation and Forecast by Categories
11.6 Asia Pacific OTC Drugs & Dietary Supplements Size Estimation and Forecast by Dosage Forms
11.7 Asia Pacific OTC Drugs & Dietary Supplements Size Estimation and Forecast by Distribution Channel
11.8 Asia Pacific OTC Drugs & Dietary Supplements Size Estimation and Forecast by Product Type
11.9 Japan OTC Drugs & Dietary Supplements Analysis
11.10 China OTC Drugs & Dietary Supplements Analysis
11.11 India OTC Drugs & Dietary Supplements Analysis
11.12 Australia OTC Drugs & Dietary Supplements Analysis
11.13 South Korea OTC Drugs & Dietary Supplements Analysis
11.14 Rest of Asia Pacific OTC Drugs & Dietary Supplements Analysis

12 Latin America OTC Drugs & Dietary Supplements Analysis
12.1 Key Findings
12.2 Latin America OTC Drugs & Dietary Supplements Attractiveness Index
12.3 Latin America OTC Drugs & Dietary Supplements by Country, 2024, 2029 & 2034 (US$ Billion)
12.4 Latin America OTC Drugs & Dietary Supplements Size Estimation and Forecast by Country
12.5 Latin America OTC Drugs & Dietary Supplements Size Estimation and Forecast by Categories
12.6 Latin America OTC Drugs & Dietary Supplements Size Estimation and Forecast by Dosage Forms
12.7 Latin America OTC Drugs & Dietary Supplements Size Estimation and Forecast by Distribution Channel
12.8 Latin America OTC Drugs & Dietary Supplements Size Estimation and Forecast by Product Type
12.9 Brazil OTC Drugs & Dietary Supplements Analysis
12.10 Mexico OTC Drugs & Dietary Supplements Analysis
12.11 Rest of Latin America OTC Drugs & Dietary Supplements Analysis

13 MEA OTC Drugs & Dietary Supplements Analysis
13.1 Key Findings
13.2 MEA OTC Drugs & Dietary Supplements Attractiveness Index
13.3 MEA OTC Drugs & Dietary Supplements by Country, 2024, 2029 & 2034 (US$ Billion)
13.4 MEA OTC Drugs & Dietary Supplements Size Estimation and Forecast by Country
13.5 MEA OTC Drugs & Dietary Supplements Size Estimation and Forecast by Categories
13.6 MEA OTC Drugs & Dietary Supplements Size Estimation and Forecast by Dosage Forms
13.7 MEA OTC Drugs & Dietary Supplements Size Estimation and Forecast by Distribution Channel
13.8 MEA OTC Drugs & Dietary Supplements Size Estimation and Forecast by Product Type
13.9 GCC OTC Drugs & Dietary Supplements Analysis
13.10 South Africa OTC Drugs & Dietary Supplements Analysis
13.11 Rest of MEA OTC Drugs & Dietary Supplements Analysis

14 Company Profiles
14.1 Competitive Landscape, 2023
14.2 Strategic Outlook
14.3 Abbott
14.3.1 Company Snapshot
14.3.2 Company Overview
14.3.3 Financial Analysis
14.3.3.1 Net Revenue, 2017-2022
14.3.3.2 R&D, 2017-2022
14.3.4 Product Benchmarking
14.3.5 Strategic Outlook
14.4 Amway Corporation
14.4.1 Company Snapshot
14.4.2 Company Overview
14.4.3 Financial Analysis
14.4.3.1 Net Revenue, 2017-2022
14.4.4 Product Benchmarking
14.4.5 Strategic Outlook
14.5 Bayer AG
14.5.1 Company Snapshot
14.5.2 Company Overview
14.5.3 Financial Analysis
14.5.3.1 Net Revenue, 2017-2022
14.5.3.2 R&D, 2017-2022
14.5.3.3 Regional Market Shares, 2022
14.5.4 Product Benchmarking
14.5.5 Strategic Outlook
14.6 Cipla, Inc.
14.6.1 Company Snapshot
14.6.2 Company Overview
14.6.3 Financial Analysis
14.6.3.1 Net Revenue, 2017-2022
14.6.3.2 Regional Market Shares, 2022
14.6.4 Product Benchmarking
14.6.5 Strategic Outlook
14.7 Dr. Reddy’s Laboratories Ltd.
14.7.1 Company Snapshot
14.7.2 Company Overview
14.7.3 Financial Analysis
14.7.3.1 Net Revenue, 2017-2022
14.7.3.2 R&D, 2017-2022
14.7.3.3 Regional Market Shares, 2022
14.7.4 Product Benchmarking
14.7.5 Strategic Outlook
14.8 Glenmark Pharmaceuticals Ltd
14.8.1 Company Snapshot
14.8.2 Company Overview
14.8.3 Financial Analysis
14.8.3.1 Net Revenue, 2017-2022
14.8.3.2 Regional Market Shares, 2022
14.8.4 Product Benchmarking
14.8.5 Strategic Outlook
14.9 GlaxoSmithKline plc
14.9.1 Company Snapshot
14.9.2 Company Overview
14.9.3 Financial Analysis
14.9.3.1 Net Revenue, 2017-2022
14.9.3.2 R&D, 2017-2022
14.9.3.3 Regional Market Shares, 2022
14.9.4 Product Benchmarking
14.9.5 Strategic Outlook
14.10 Herbalife Nutrition
14.10.1 Company Snapshot
14.10.2 Company Overview
14.10.3 Financial Analysis
14.10.3.1 Net Revenue, 2017-2022
14.10.3.2 Regional Market Shares, 2022
14.10.4 Product Benchmarking
14.10.5 Strategic Outlook
14.11 Kenvue Inc. (Previously J & J Services Business Division)
14.11.1 Company Snapshot
14.11.2 Company Overview
14.11.3 Financial Analysis
14.11.3.1 Net Revenue, 2017-2022
14.11.3.2 R&D, 2017-2022
14.11.3.3 Regional Market Shares, 2022
14.11.4 Product Benchmarking
14.11.5 Strategic Outlook
14.12 Nestle SA
14.12.1 Company Snapshot
14.12.2 Company Overview
14.12.3 Financial Analysis
14.12.3.1 Net Revenue, 2017-2022
14.12.3.2 R&D, 2017-2022
14.12.3.3 Regional Market Shares, 2022
14.12.4 Product Benchmarking
14.12.5 Strategic Outlook
14.13 Perrigo Company Inc,
14.13.1 Company Snapshot
14.13.2 Company Overview
14.13.3 Financial Analysis
14.13.3.1 Net Revenue, 2017-2022
14.13.3.2 R&D, 2017-2022
14.13.3.3 Regional Market Shares, 2022
14.13.4 Product Benchmarking
14.13.5 Strategic Outlook
14.14 Pfizer Inc.
14.14.1 Company Snapshot
14.14.2 Company Overview
14.14.3 Financial Analysis
14.14.3.1 Net Revenue, 2017-2022
14.14.3.2 R&D, 2017-2022
14.14.3.3 Regional Market Shares, 2022
14.14.4 Product Benchmarking
14.14.5 Strategic Outlook
14.15 Sanofi
14.15.1 Company Snapshot
14.15.2 Company Overview
14.15.3 Financial Analysis
14.15.3.1 Net Revenue, 2017-2022
14.15.3.2 R&D, 2017-2022
14.15.4 Product Benchmarking
14.15.5 Strategic Outlook
14.16 Sun Pharmaceutical Industries Ltd
14.16.1 Company Snapshot
14.16.2 Company Overview
14.16.3 Financial Analysis
14.16.3.1 Net Revenue, 2017-2022
14.16.3.2 Regional Market Shares, 2022
14.16.4 Product Benchmarking
14.16.5 Strategic Outlook

15 Conclusion and Recommendations
15.1 Concluding Remarks from Visiongain
15.2 Recommendations for Market Players

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1 OTC Drugs & Dietary Supplements Snapshot, 2024 & 2034 (US$ Billion, CAGR %)
Table 2 OTC Drugs & Dietary Supplements Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%): “V” Shaped Recovery
Table 3 OTC Drugs & Dietary Supplements Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%): “U” Shaped Recovery
Table 4 OTC Drugs & Dietary Supplements Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%): “W” Shaped Recovery
Table 5 OTC Drugs & Dietary Supplements Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%): “L” Shaped Recovery
Table 6 OTC Drugs & Dietary Supplements Forecast by Categories, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 7 Analgesics Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 8 Cold, Cough and Flu Products Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 9 Gastrointestinal Products Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 10 Ophthalmic Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 11 Feminine Care Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 12 Vitamin and Dietary Supplements Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 13 Sleep Aids Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 14 Wart Removers Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 15 Mouth Care Products Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 16 Botanicals Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 17 Smoking Cessation Products Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 18 OTC Drugs & Dietary Supplements Forecast by Dosage Forms, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 19 Tablets Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 20 Capsules Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 21 Powder Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 22 Ointments Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 23 Soft Capsules Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 24 Liquids Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 25 Others Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 26 OTC Drugs & Dietary Supplements Distribution Channel, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 27 Pharmacies Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 28 Vitamin & Health Food Store Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 29 Online Pharmacy Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 30 Grocery Stores Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 31 OTC Drugs & Dietary Supplements Product Type, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 32 Branded Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 33 Generic Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 34 OTC Drugs & Dietary Supplements Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 35 North America OTC Drugs & Dietary Supplements Forecast by Country, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 36 OTC Drugs & Dietary Supplements Forecast by Categories, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 37 North America OTC Drugs & Dietary Supplements Forecast by Dosage Forms, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 38 OTC Drugs & Dietary Supplements Distribution Channel, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 39 North America OTC Drugs & Dietary Supplements Product Type, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 40 U.S. OTC Drugs & Dietary Supplements Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 41 Canada OTC Drugs & Dietary Supplements Forecast, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 42 Europe OTC Drugs & Dietary Supplements Forecast by Country, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 43 Europe OTC Drugs & Dietary Supplements Forecast by Categories, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 44 Europe OTC Drugs & Dietary Supplements Forecast by Dosage Forms, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 45 OTC Drugs & Dietary Supplements Distribution Channel, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 46 Europe OTC Drugs & Dietary Supplements Product Type, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 47 Germany OTC Drugs & Dietary Supplements Forecast, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 48 France OTC Drugs & Dietary Supplements Forecast, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 49 UK OTC Drugs & Dietary Supplements Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 50 Italy OTC Drugs & Dietary Supplements Forecast, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 51 Spain OTC Drugs & Dietary Supplements Forecast, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 52 Russia OTC Drugs & Dietary Supplements Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 53 Rest of Europe OTC Drugs & Dietary Supplements Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 54 Asia Pacific OTC Drugs & Dietary Supplements Forecast by Country, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 55 Asia Pacific OTC Drugs & Dietary Supplements Forecast by Categories, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 56 OTC Drugs & Dietary Supplements Forecast by Dosage Forms, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 57 OTC Drugs & Dietary Supplements Distribution Channel, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 58 Asia Pacific OTC Drugs & Dietary Supplements Product Type, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 59 Japan OTC Drugs & Dietary Supplements Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 60 China OTC Drugs & Dietary Supplements Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 61 India OTC Drugs & Dietary Supplements Forecast, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 62 Australia OTC Drugs & Dietary Supplements Forecast, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 63 South Korea OTC Drugs & Dietary Supplements Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 64 Rest of Asia Pacific OTC Drugs & Dietary Supplements Forecast, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 65 Latin America OTC Drugs & Dietary Supplements Forecast by Country, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 66 OTC Drugs & Dietary Supplements Forecast by Categories, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 67 OTC Drugs & Dietary Supplements Forecast by Dosage Forms, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 68 OTC Drugs & Dietary Supplements Distribution Channel, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 69 Latin America OTC Drugs & Dietary Supplements Product Type, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 70 Brazil OTC Drugs & Dietary Supplements Forecast, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 71 Mexico OTC Drugs & Dietary Supplements Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 72 Rest of Latin America OTC Drugs & Dietary Supplements Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 73 MEA OTC Drugs & Dietary Supplements Forecast by Country, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 74 OTC Drugs & Dietary Supplements Forecast by Categories, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 75 OTC Drugs & Dietary Supplements Forecast by Dosage Forms, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 76 OTC Drugs & Dietary Supplements Distribution Channel, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 77 MEA OTC Drugs & Dietary Supplements Product Type, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 78 GCC OTC Drugs & Dietary Supplements Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 79 South Africa OTC Drugs & Dietary Supplements Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 80 Rest of MEA OTC Drugs & Dietary Supplements Forecast, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 81 Strategic Outlook
Table 82 Abbott: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 83 Abbott: Product Benchmarking
Table 84 Abbott: Strategic Outlook
Table 85 Amway Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 86 Amway Corporation: Product Benchmarking
Table 87 Amway Corporation: Strategic Outlook
Table 88 Bayer AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 89 Bayer AG: Product Benchmarking
Table 90 Bayer AG: Strategic Outlook
Table 91 Cipla, Inc. Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 92 Cipla, Inc.: Product Benchmarking
Table 93 Cipla, Inc.: Strategic Outlook
Table 94 Dr. Reddy’s Laboratories Ltd: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 95 Dr. Reddy’s Laboratories Ltd: Product Benchmarking
Table 96 Dr. Reddy’s Laboratories Ltd: Strategic Outlook
Table 97 Glenmark Pharmaceuticals Ltd: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 98 Glenmark Pharmaceuticals Ltd: Product Benchmarking
Table 99 Glenmark Pharmaceuticals Ltd: Strategic Outlook
Table 100 GlaxoSmithKline plc; Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 101 GlaxoSmithKline plc: Product Benchmarking
Table 102 GlaxoSmithKline plc: Strategic Outlook
Table 103 Herbalife Nutrition: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 104 Herbalife Nutrition: Product Benchmarking
Table 105 Herbalife Nutrition: Strategic Outlook
Table 106 Kenvue Inc. (Previously J & J Services Business Division).: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 107 Kenvue Inc. (Previously J & J Services Business Division): Product Benchmarking
Table 108 Kenvue Inc. (Previously J & J Services Business Division): Strategic Outlook
Table 109 Nestle SA: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 110 Nestle SA: Product Benchmarking
Table 111 Nestle SA: Strategic Outlook
Table 112 Perrigo Company Inc, Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 113 Perrigo Company Inc, Product Benchmarking
Table 114 Perrigo Company Inc, Strategic Outlook
Table 115 Pfizer Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 116 Pfizer Inc.: Product Benchmarking
Table 117 Pfizer Inc.: Strategic Outlook
Table 118 Sanofi: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 119 Sanofi: Product Benchmarking
Table 120 Sanofi: Strategic Outlook
Table 121 Sun Pharmaceutical Industries Ltd: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 122 Sun Pharmaceutical Industries Ltd: Product Benchmarking
Table 123 Sun Pharmaceutical Industries Ltd: Strategic Outlook

List of Figures
Figure 1 OTC Drugs & Dietary Supplements Segmentation
Figure 2 OTC Drugs & Dietary Supplements Market by Categories: Market Attractiveness Index
Figure 3 OTC Drugs & Dietary Supplements by Dosage Forms: Market Attractiveness Index
Figure 4 OTC Drugs & Dietary Supplements by Distribution Channel: Market Attractiveness Index
Figure 5 OTC Drugs & Dietary Supplements by Product Type: Market Attractiveness Index
Figure 6 OTC Drugs & Dietary Supplements Attractiveness Index by Region
Figure 7 OTC Drugs & Dietary Supplements: Market Dynamics
Figure 8 OTC Drugs & Dietary Supplements by Region, 2024-2034 (US$ Billion, AGR %): “V” Shaped Recovery
Figure 9 OTC Drugs & Dietary Supplements by Region, 2024-2034 (US$ Billion, AGR %): “U” Shaped Recovery
Figure 10 OTC Drugs & Dietary Supplements by Region, 2024-2034 (US$ Billion, AGR %): “W” Shaped Recovery
Figure 11 OTC Drugs & Dietary Supplements by Region, 2024-2034 (US$ Billion, AGR %): “L” Shaped Recovery
Figure 12 OTC Drugs & Dietary Supplements Market: Porter’s Five Forces Analysis
Figure 13 OTC Drugs & Dietary Supplements: PEST Analysis
Figure 14 OTC Drugs & Dietary Supplements by Categories: Market Attractiveness Index
Figure 15 OTC Drugs & Dietary Supplements Forecast by Categories, 2024-2034 (US$ Billion, AGR %)
Figure 16 OTC Drugs & Dietary Supplements Share Forecast by Categories, 2024, 2029, 2034 (%)
Figure 17 Analgesics Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 18 Analgesics Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 19 Cold, Cough and Flu Products Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 20 Cold, Cough and Flu Products Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 21 Gastrointestinal Products Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 22 Gastrointestinal Products Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 23 Ophthalmic Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 24 Ophthalmic Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 25 Feminine Care Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 26 Feminine Care Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 27 Vitamin and Dietary Supplements Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 28 Vitamin and Dietary Supplements Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 29 Sleep Aids Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 30 Sleep Aids Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 31 Wart Removers Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 32 Wart Removers Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 33 Mouth Care Products Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 34 Mouth Care Products Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 35 Botanicals Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 36 Botanicals Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 37 Smoking Cessation Products Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 38 Smoking Cessation Products Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 39 OTC Drugs & Dietary Supplements by Dosage Forms: Market Attractiveness Index
Figure 40 OTC Drugs & Dietary Supplements Forecast by Dosage Forms, 2024-2034 (US$ Billion, AGR %)
Figure 41 OTC Drugs & Dietary Supplements Share Forecast by Dosage Forms, 2024, 2029, 2034 (%)
Figure 42 Tablets Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 43 Tablets Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 44 Capsules Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 45 Capsules Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 46 Powder Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 47 Powder Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 48 Ointments Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 49 Ointments Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 50 Soft Capsules Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 51 Soft Capsules Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 52 Liquids Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 53 Liquids Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 54 Others Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 55 Others Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 56 OTC Drugs & Dietary Supplements by Distribution Channel: Market Attractiveness Index
Figure 57 OTC Drugs & Dietary Supplements Forecast by Distribution Channel, 2024-2034 (US$ Billion, AGR %)
Figure 58 Active Pharmaceutical Ingredients Market Share Forecast by Distribution Channel, 2024, 2029, 2034 (%)
Figure 59 Pharmacies Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 60 Pharmacies Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 61 Vitamin & Health Food Store Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 62 Vitamin & Health Food Store Market Share Forecast by Region, 2024 & 2034 (%)
Figure 63 Online Pharmacy Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 64 Online Pharmacy Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 65 Grocery Stores Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 66 Grocery Stores Market Share Forecast by Region, 2024 & 2034 (%)
Figure 67 OTC Drugs & Dietary Supplements by Product Type: Market Attractiveness Index
Figure 68 OTC Drugs & Dietary Supplements Forecast by Product Type, 2024-2034 (US$ Billion, AGR %)
Figure 69 OTC Drugs & Dietary Supplements Share Forecast by Product Type, 2024, 2029, 2034 (%)
Figure 70 Branded Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 71 Branded Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 72 Generic Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 73 Generic Market Share Forecast by Region, 2024 & 2034 (%)
Figure 74 OTC Drugs & Dietary Supplements Forecast by Region 2023 and 2033 (Revenue, CAGR %)
Figure 75 Active Pharmaceutical Ingredients Market Share Forecast by Region 2024, 2029, 2034 (%)
Figure 76 OTC Drugs & Dietary Supplements by Region, 2024-2034 (US$ Billion, AGR %)
Figure 77 North America OTC Drugs & Dietary Supplements Attractiveness Index
Figure 78 North America OTC Drugs & Dietary Supplements by Region, 2024, 2029 & 2034 (US$ Billion)
Figure 79 North America OTC Drugs & Dietary Supplements Forecast by Country, 2024-2034 (US$ Billion, AGR %)
Figure 80 North America OTC Drugs & Dietary Supplements Share Forecast by Country, 2024 & 2034 (%)
Figure 81 North America OTC Drugs & Dietary Supplements Forecast by Categories, 2024-2034 (US$ Billion, AGR %)
Figure 82 North America OTC Drugs & Dietary Supplements Share Forecast by Categories, 2024 & 2034 (%)
Figure 83 North America OTC Drugs & Dietary Supplements Forecast by Dosage Forms, 2024-2034 (US$ Billion, AGR %)
Figure 84 North America OTC Drugs & Dietary Supplements Share Forecast by Dosage Forms, 2024 & 2034 (%)
Figure 85 North America OTC Drugs & Dietary Supplements Forecast by Distribution Channel, 2024-2034 (US$ Billion, AGR %)
Figure 86 North America OTC Drugs & Dietary Supplements Share Forecast by Distribution Channel, 2024 & 2034 (%)
Figure 87 North America OTC Drugs & Dietary Supplements Forecast by Product Type, 2024-2034 (US$ Billion, AGR %)
Figure 88 North America OTC Drugs & Dietary Supplements Share Forecast by Product Type, 2024 & 2034 (%)
Figure 89 U.S. OTC Drugs & Dietary Supplements Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 90 Canada OTC Drugs & Dietary Supplements Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 91 Europe OTC Drugs & Dietary Supplements Attractiveness Index
Figure 92 Europe OTC Drugs & Dietary Supplements by Region, 2024, 2029 & 2034 (US$ Billion)
Figure 93 Europe OTC Drugs & Dietary Supplements Forecast by Country, 2024-2034 (US$ Billion, AGR %)
Figure 94 Europe OTC Drugs & Dietary Supplements Share Forecast by Country, 2024 & 2034 (%)
Figure 95 Europe OTC Drugs & Dietary Supplements Forecast by Categories, 2024-2034 (US$ Billion, AGR %)
Figure 96 Europe OTC Drugs & Dietary Supplements Share Forecast by Categories, 2024 & 2034 (%)
Figure 97 Europe OTC Drugs & Dietary Supplements Forecast by Dosage Forms, 2024-2034 (US$ Billion, AGR %)
Figure 98 Europe OTC Drugs & Dietary Supplements Share Forecast by Dosage Forms, 2024 & 2034 (%)
Figure 99 Europe OTC Drugs & Dietary Supplements Forecast by Distribution Channel, 2024-2034 (US$ Billion, AGR %)
Figure 100 Europe OTC Drugs & Dietary Supplements Share Forecast by Distribution Channel, 2024 & 2034 (%)
Figure 101 Europe OTC Drugs & Dietary Supplements Forecast by Product Type, 2024-2034 (US$ Billion, AGR %)
Figure 102 Europe OTC Drugs & Dietary Supplements Share Forecast by Product Type, 2024 & 2034 (%)
Figure 103 Germany OTC Drugs & Dietary Supplements Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 104 France OTC Drugs & Dietary Supplements Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 105 UK OTC Drugs & Dietary Supplements Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 106 Italy OTC Drugs & Dietary Supplements Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 107 Spain OTC Drugs & Dietary Supplements Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 108 Russia OTC Drugs & Dietary Supplements Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 109 Rest of Europe OTC Drugs & Dietary Supplements Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 110 Asia Pacific OTC Drugs & Dietary Supplements Attractiveness Index
Figure 111 Asia Pacific OTC Drugs & Dietary Supplements by Region, 2024, 2029 & 2034 (US$ Billion)
Figure 112 Asia Pacific OTC Drugs & Dietary Supplements Forecast by Country, 2024-2034 (US$ Billion, AGR %)
Figure 113 Asia Pacific OTC Drugs & Dietary Supplements Share Forecast by Country, 2024 & 2034 (%)
Figure 114 Asia Pacific OTC Drugs & Dietary Supplements Forecast by Categories, 2024-2034 (US$ Billion, AGR %)
Figure 115 Asia Pacific OTC Drugs & Dietary Supplements Share Forecast by Categories, 2024 & 2034 (%)
Figure 116 Asia Pacific OTC Drugs & Dietary Supplements Forecast by Dosage Forms, 2024-2034 (US$ Billion, AGR %)
Figure 117 Asia Pacific OTC Drugs & Dietary Supplements Share Forecast by Dosage Forms, 2024 & 2034 (%)
Figure 118 Asia Pacific OTC Drugs & Dietary Supplements Forecast by Distribution Channel, 2024-2034 (US$ Billion, AGR %)
Figure 119 Asia Pacific OTC Drugs & Dietary Supplements Share Forecast by Distribution Channel, 2024 & 2034 (%)
Figure 120 Asia Pacific OTC Drugs & Dietary Supplements Forecast by Product Type, 2024-2034 (US$ Billion, AGR %)
Figure 121 Asia Pacific OTC Drugs & Dietary Supplements Share Forecast by Product Type, 2024 & 2034 (%)
Figure 122 Japan OTC Drugs & Dietary Supplements Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 123 China OTC Drugs & Dietary Supplements Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 124 India OTC Drugs & Dietary Supplements Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 125 Australia OTC Drugs & Dietary Supplements Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 126 South Korea OTC Drugs & Dietary Supplements Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 127 Rest of Asia Pacific OTC Drugs & Dietary Supplements Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 128 Latin America OTC Drugs & Dietary Supplements Attractiveness Index
Figure 129 Latin America OTC Drugs & Dietary Supplements by Region, 2024, 2029 & 2034 (US$ Billion)
Figure 130 Latin America OTC Drugs & Dietary Supplements Forecast by Country, 2024-2034 (US$ Billion, AGR %)
Figure 131 Latin America OTC Drugs & Dietary Supplements Share Forecast by Country, 2024 & 2034 (%)
Figure 132 Latin America OTC Drugs & Dietary Supplements Forecast by Categories, 2024-2034 (US$ Billion, AGR %)
Figure 133 Latin America OTC Drugs & Dietary Supplements Share Forecast by Categories, 2024 & 2034 (%)
Figure 134 Latin America OTC Drugs & Dietary Supplements Forecast by Dosage Forms, 2024-2034 (US$ Billion, AGR %)
Figure 135 Latin America OTC Drugs & Dietary Supplements Share Forecast by Dosage Forms, 2024 & 2034 (%)
Figure 136 Latin America OTC Drugs & Dietary Supplements Forecast by Distribution Channel, 2024-2034 (US$ Billion, AGR %)
Figure 137 Latin America OTC Drugs & Dietary Supplements Share Forecast by Distribution Channel, 2024 & 2034 (%)
Figure 138 Latin America OTC Drugs & Dietary Supplements Forecast by Product Type, 2024-2034 (US$ Billion, AGR %)
Figure 139 Latin America OTC Drugs & Dietary Supplements Share Forecast by Product Type, 2024 & 2034 (%)
Figure 140 Brazil OTC Drugs & Dietary Supplements Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 141 Mexico OTC Drugs & Dietary Supplements Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 142 Rest of Latin America OTC Drugs & Dietary Supplements Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 143 MEA OTC Drugs & Dietary Supplements Attractiveness Index
Figure 144 MEA OTC Drugs & Dietary Supplements by Region, 2024, 2029 & 2034 (US$ Billion)
Figure 145 MEA OTC Drugs & Dietary Supplements Forecast by Country, 2024-2034 (US$ Billion, AGR %)
Figure 146 MEA OTC Drugs & Dietary Supplements Share Forecast by Country, 2024 & 2034 (%)
Figure 147 MEA OTC Drugs & Dietary Supplements Forecast by Categories, 2024-2034 (US$ Billion, AGR %)
Figure 148 MEA OTC Drugs & Dietary Supplements Share Forecast by Categories, 2024 & 2034 (%)
Figure 149 MEA OTC Drugs & Dietary Supplements Forecast by Dosage Forms, 2024-2034 (US$ Billion, AGR %)
Figure 150 MEA OTC Drugs & Dietary Supplements Share Forecast by Dosage Forms, 2024 & 2034 (%)
Figure 151 MEA OTC Drugs & Dietary Supplements Forecast by Distribution Channel, 2024-2034 (US$ Billion, AGR %)
Figure 152 MEA OTC Drugs & Dietary Supplements Share Forecast by Distribution Channel, 2024 & 2034 (%)
Figure 153 MEA OTC Drugs & Dietary Supplements Forecast by Product Type, 2024-2034 (US$ Billion, AGR %)
Figure 154 MEA OTC Drugs & Dietary Supplements Share Forecast by Product Type, 2024 & 2034 (%)
Figure 155 GCC OTC Drugs & Dietary Supplements Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 156 South Africa OTC Drugs & Dietary Supplements Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 157 Rest of MEA OTC Drugs & Dietary Supplements Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 158 OTC Drugs & Dietary Supplements Market: Company Share, 2023
Figure 159 Abbott: Net Revenue, 2017-2022 (US$ Million, AGR %)
Figure 160 Abbott: R&D, 2017-2022 (US$ Million, AGR %)
Figure 161 Amway Corporation: Net Revenue, 2017-2022 (US$ Million, AGR %)
Figure 162 Bayer AG: Net Revenue, 2017-2022 (US$ Million, AGR %)
Figure 163 Bayer AG: R&D, 2017-2022 (US$ Million, AGR%)
Figure 164 Bayer AG: Regional Market Shares, 2022
Figure 165 Cipla, Inc. Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 166 Cipla Inc,. Regional Market Shares, 2022
Figure 167 Dr. Reddy’s Laboratories Ltd: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 168 Dr. Reddy’s Laboratories Ltd: R&D, 2017-2022 (US$ Million, AGR%)
Figure 169 Dr. Reddy’s Laboratories Ltd: Regional Market Shares, 2022
Figure 170 Glenmark Pharmaceuticals Ltd: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 171 Glenmark Pharmaceuticals Ltd: Regional Market Shares, 2022
Figure 172 GlaxoSmithKline plc ; Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 173 GlaxoSmithKline plc; R&D, 2017-2022 (US$ Million, AGR%)
Figure 174 GlaxoSmithKline plc ; Regional Market Shares, 2022
Figure 175 Herbalife Nutrition: Net Revenue, 2017-2022 (US$ Million, AGR %)
Figure 176 Herbalife Nutrition: Regional Market Shares, 2022
Figure 177 Kenvue Inc. (Previously J & J Services Business Division).: Net Revenue, 2017-2022 (US$ Million, AGR %)
Figure 178 Kenvue Inc. (Previously J & J Services Business Division).: R&D, 2017-2022 (US$ Million, AGR%)
Figure 179 Kenvue Inc. (Previously J & J Services Business Division): Regional Market Shares, 2022
Figure 180 Nestle SA: Net Revenue, 2017-2022 (US$ Million, AGR %)
Figure 181 Nestle SA: R&D, 2017-2022 (US$ Million, AGR %)
Figure 182 Nestle SA: Regional Market Shares, 2022
Figure 183 Perrigo Company Inc, Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 184 Perrigo Company Inc, R&D, 2017-2022 (US$ Million, AGR%)
Figure 185 Perrigo Company Inc, Regional Market Shares, 2022
Figure 186 Pfizer Inc.: Net Revenue, 2017-2022 (US$ Million, AGR %)
Figure 187 Pfizer Inc.: R&D, 2017-2022 (US$ Million, AGR %)
Figure 188 Pfizer Inc.: Regional Market Shares, 2022
Figure 189 Sanofi: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 190 Sanofi: R&D, 2017-2022 (US$ Million, AGR%)
Figure 191 Sun Pharmaceutical Industries Ltd: Net Revenue, 2017-2022 (US$ Million, AGR %)
Figure 192 Sun Pharmaceutical Industries Ltd: Regional Market Shares, 2022

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野の最新刊レポート

本レポートと同分野の最新刊レポートはありません。

Visiongain 社の最新刊レポート

本レポートと同じKEY WORD（covid19）の最新刊レポート

よくあるご質問

Visiongain社はどのような調査会社ですか?

英国の調査会社ヴィジョンゲイン社（Visiongain）は、通信とエネルギーのほか、自動車や化学・医薬品、金属など、広範な市場を対象に調査を行っています。自動車市場については、市場全般に関する調査のほ... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

OTC医薬品と栄養補助食品市場レポート：2024-2034

サマリー

目次

図表リスト

Summary

Table of Contents

List of Tables/Graphs

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野の最新刊レポート

Visiongain 社の最新刊レポート

本レポートと同じKEY WORD（covid19）の最新刊レポート

よくあるご質問

Visiongain社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?